Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma

Alberto Repici,Alessio Ardizzone,Fabiola De Luca,Lorenzo Colarossi,Angela Prestifilippo,Gabriele Pizzino,Irene Paterniti,Emanuela Esposito,Anna Paola Capra

DOI: https://doi.org/10.3390/cells13040361

IF: 6

2024-02-20

Cells

Abstract:Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence rate in people of all ages around the globe. In this pathological context, glioblastoma, a form of glioma that belongs to the IV-grade astrocytoma group, is the most common and most aggressive form of the primary brain tumors. Indeed, despite the best treatments available including surgery, radiotherapy or a pharmacological approach with Temozolomide, glioblastoma patients' mortality is still high, within a few months of diagnosis. Therefore, to increase the chances of these patients surviving, it is critical to keep finding novel treatment opportunities. In the past, efforts to treat glioblastoma have mostly concentrated on customized treatment plans that target specific mutations such as epidermal growth factor receptor (EGFR) mutations, Neurotrophic Tyrosine Receptor Kinase (NTRK) fusions, or multiple receptors using multi-kinase inhibitors like Sunitinib and Regorafenib, with varying degrees of success. Here, we focused on the receptor tyrosine kinase AXL that has been identified as a mediator for tumor progression and therapy resistance in various cancer types, including squamous cell tumors, small cell lung cancer, and breast cancer. Activated AXL leads to a significant increase in tumor proliferation, tumor cell migration, and angiogenesis in different in vitro and in vivo models of cancer since this receptor regulates interplay with apoptotic, angiogenic and inflammatory pathways. Based on these premises, in this review we mainly focused on the role of AXL in the course of glioblastoma, considering its primary biological mechanisms and as a possible target for the application of the most recent treatments.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the signaling pathway of AXL receptor tyrosine kinase in glioblastoma and its contribution to the disease - generating mechanism. Specifically, the paper focuses on how the AXL receptor affects tumor growth, migration, angiogenesis, and the interaction with apoptosis and inflammation pathways through its signaling pathway. These mechanisms are crucial for understanding the complex biological network of glioblastoma and may provide potential targets for the development of new treatment methods. Therefore, this study aims to evaluate the molecular mechanism of the AXL receptor in glioblastoma, especially its potential as a treatment target.